| Trial registration number
|
IRCT20210615051590N1 |
Full text link
Last imported at : July 15, 2021, 12:30 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
http://en.irct.ir/trial/56941
|
First author
Last imported at : July 15, 2021, 12:30 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Alireza Kamali
|
Contact
Last imported at : July 15, 2021, 12:30 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
research@arakmu.ac.ir
|
Registration date
Last imported at : July 15, 2021, 12:30 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
2021-07-15
|
Recruitment status
Last imported at : Sept. 22, 2021, 2:30 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Completed
|
Study design
Last imported at : July 15, 2021, 12:30 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
RCT
|
Allocation
Last imported at : July 15, 2021, 12:30 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Randomized
|
Design
Last imported at : July 15, 2021, 12:30 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Parallel
|
Masking
Last imported at : July 15, 2021, 12:30 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Blind label
|
Center
Last imported at : July 15, 2021, 12:30 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
single-center
|
Study aim
Last imported at : July 15, 2021, 12:30 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Treatment
|
Inclusion criteria
Last imported at : July 15, 2021, 12:30 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Age between 18 and 70 years
Positive PCR sample
Blood oxygen level less than 94
Respiratory rate more than 30 per minute
|
Exclusion criteria
Last imported at : July 15, 2021, 12:30 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Presence of serious heart disease , malignancy, ESRD, organ transplantation , pregnancy
contraindications to the use of omega-3 pills
|
Number of arms
Last imported at : July 15, 2021, 12:30 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
2
|
Funding
Last imported at : July 15, 2021, 12:30 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Arak University of Medical Sciences
|
Inclusion age min
Last imported at : July 15, 2021, 12:30 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
18
|
Inclusion age max
Last imported at : July 15, 2021, 12:30 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
70
|
Countries
Last imported at : July 15, 2021, 12:30 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Iran
|
Type of patients
Last imported at : July 15, 2021, 12:30 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Severe/critical disease at enrollment
|
Severity scale
Last imported at : July 15, 2021, 12:30 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
7: Severe/critical disease at enrollment
|
Total sample size
Last imported at : July 15, 2021, 12:30 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
80
|
primary outcome
Last imported at : July 15, 2021, 12:30 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Recovery of patients with Quid 19
|
Notes
Last imported at : July 15, 2021, 12:30 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
|
Phase
Last imported at : July 15, 2021, 12:30 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Phase 3
|
Arms
Last imported at : July 15, 2021, 12:30 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
[{"arm_notes": "", "treatment_id": 925, "treatment_name": "Omega 3 fatty acid", "treatment_type": "Vitamins and dietary supplements", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}]
|